SCHEMBL485191

SCHEMBL485191

COc1ccc(C(C(=O)C(c2ccc(OC)c(OC)c2)c2cc(Cl)c(O)cc2O)c2cc(Cl)c(O)cc2O)cc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
HTT P42858 2/20 0.42
ACHE P22303 2/20 0.42
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
TNF P01375 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
BLM P54132 1/20 0.40
TSHR P16473 1/20 0.40
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MITF O75030 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HSP90AB1 P08238 1/20 0.39
MCL1 Q07820 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485336 0.83 HSP90AA1 (0.45) HSP90AA1NPC1RAB9AKMT2AMEN1
SCHEMBL1010039 0.80 HSP90AA1 (0.41) HSP90AA1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL485062 0.79 HSP90AA1 (0.42) HSP90AA1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL484707 0.76 DPP4 (0.45) HSP90AA1KMT2AMEN1HTTTSHR
SCHEMBL4436344 0.69 ALDH1A1 (0.46) SMN1; SMN2KMT2AMEN1HTTACHE
SCHEMBL4431771 0.69 NPSR1 (0.43) SMN1; SMN2NPC1RAB9AKMT2AMEN1
SCHEMBL8193391 0.68 ACHE (0.54) SMN1; SMN2KMT2AACHECA1CA2
SCHEMBL28796509 0.68 MEN1 (0.43) NPC1RAB9AKMT2AMEN1HTT
SCHEMBL484983 0.68 HSP90AA1 (0.66) HSP90AA1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL17977154 0.67 CA1 (0.45) HSP90AA1SMN1; SMN2RAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314132-B2 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of Hsp90 chaperone and the intermediates for production thereof BIOTECHNOLOGIJOS INSTITUTAS (LT) 2012-11-20 US claimed
EP-2268626-B1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF BIOTECHNOLOGIJOS INST (LT) 2012-02-01 EP claimed
US-20110046387-A1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF BIOTECHNOLOGIJOS INSTITUTAS (LT) 2011-02-24 US claimed
EP-2268626-A1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF Biotechnologijos Institutas (LT) 2011-01-05 EP claimed
WO-2009134110-A1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF BIOTECHNOLOGIJOS INSTITUTAS (LT) 2009-11-05 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046387-A1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF HSP90AB1, HSP90AB2P, HSP90AA1 HSP90AA1 3/4885SMN1; SMN2 4502/4885NPC1 1660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.